Professor Shlomo Ben-Haim, a renowned medical device entrepreneur, has an impressive record of co-founding companies and maximizing their value. He has held faculty appointments as a Professor of Medicine, Physiology and Biophysics at both Harvard University and the Technion – Israel Institute of Technology. Professor Ben-Haim’s education was in Medicine and Biophysics. He has published over 200 scientific papers in peer-reviewed journals, and is the recipient of a long list of prizes for his research and inventions. Professor Ben-Haim is the inventor of more than 550 patents and patent applications worldwide, including those for a navigated cardiac catheterization system and an implantable device for treating congestive heart failure and diabetes. Professor Ben-Haim is now focusing on building businesses in healthcare that improve patient health, and reduce total healthcare spending.
Simos Kedikoglou, MD
Chief Executive Officer (CEO)
Dr. Simos Kedikoglou became our CEO in 2013 and serves on the Company’s Board of Directors. He was previously CEO of MedInvest, an Israeli Medical Technology Incubator overseeing 10 portfolio companies with responsibility for their clinical and commercial strategy, technology development and debt and equity financing. He has also served as Corporate Vice President of Business Development for Boston Scientific responsible for acquisitions, licensing and distribution deals in the US, Europe and Asia and an Associate Partner with McKinsey & Company in the US advising clients on acquisitions in pharmaceuticals and medical devices. Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction from Harvard Business School as well as a Master’s in Public Health from Harvard University, and he is a CFA Charterholder.
Ms. Erony has more than 30 years experience as a principal in investing activities, business development and investment banking. Prior to founding Majalin in 2015, she was a Managing Director at Signet Healthcare Partners, a growth capital healthcare fund in New York. Joyce has led or co-led investments Inspire Medical Systems (IPO), Essential Medical (sale), Icon Biosystems (sale), Peak Surgical (sale), Dow Parma Sciences (sale), Anteis (sale), and Atlantis (sale). She is currently a Director of Inspire Medical Systems and Miach. Based in New York City, Ms. Erony leads the Firm’s activities in med tech and specialty pharma.
Previously, Ms. Erony was a strategic advisor to Alcon Labs and a Managing Director at Citigroup responsible for the Bank’s activities in specialty pharmaceuticals and medical devices.
A senior executive with 35 years’ experience of the international medical devices industry, 15 years of which have been at Board level. For the past 11 years he has been President at Biosensors International, two years as CEO where Biosensors has grown from a start-up to become the fourth largest supplier of cardiac stents in the world. In addition to his roles at Biosensors he has served as a Non-Executive Director on the Board of various medical device companies including PneumRx, Veryan Medical, Maya, Benechill, Anecova and ARTS. He was chairman of Biosensors Europe and served on the board of Biosensors International, as well as Biosensors Singapore, India, France, Japan, Germany, Spain, and Brazil. Jeff is currently Chairman of MedAlliance SA, Chairman of Manli Cardiology, and an independent board member for Veryan, Symetis and Impulse Dynamics.
Mr. Chan is the Investment Director of Henderson (China) Investment Ltd, and has 14 years of experience in Asset Management, M&A, Venture Capital and Private Equity. So far, Mr. Chan managed over US$1 billion of investment. Prior to joining Henderson, he worked as Senior Vice President and Head of Private Equity for CCB International and CMS Capital respectively. Mr. Chan holds a Bachelor’s degree in Finance and Economics from The University of Melbourne and a Master’s degree in Applied Finance from The Monash University (Melbourne).
Mr. Ray Yang joined CITIC Group in 2011 and has been active in the global investment field. In his eight-year investment career, he has successfully instructed dozens of domestic and foreign companies in investment and divestment operations, such as United Imagining, Genomics, and Impulse Dynamics. Mr. Ray Yang holds a bachelor’s degree in engineering, a master’s degree in management science and engineering from Tsinghua University, and a master’s degree in engineering from the University of Aachen, Germany.
Mr. Owers joined Impulse Dynamics N.V. in 2001 and is responsible for all aspects of the Curaçao-based Company. He was with the accounting firm KPMG from 1969-98 in London, São Paulo, Brazil and Curaçao, the latter as a Senior Partner for many years. He has been a Fellow of the Institute of Chartered Accountants in England and Wales since 1980, and has been British consul to the Dutch Caribbean islands since 1997. He is also treasurer of many charitable foundations in the Netherlands Antilles including the Red Cross, International School, National Trust, Consular Corps, Rotary and Uniting for Children.